Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy C4 Therapeutics Inc stock

Learn how to easily invest in C4 Therapeutics Inc stock.

C4 Therapeutics Inc is a biotechnology business based in the US. C4 Therapeutics Inc shares (CCCC) are listed on the NASDAQ and all prices are listed in US Dollars. C4 Therapeutics Inc employs 146 staff and has a trailing 12-month revenue of around $31.1 million.

How to buy C4 Therapeutics Inc stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – CCCC. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award

eToro


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for options trading

tastytrade


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

C4 Therapeutics Inc stock price (NASDAQ: CCCC)

Use our graph to track the performance of CCCC stocks over time.

C4 Therapeutics Inc shares at a glance

Information last updated 2023-03-30.
Latest market close$3.14
52-week range$3.00 - $26.80
50-day moving average $5.58
200-day moving average $8.12
Wall St. target price$22.42
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.52

Buy C4 Therapeutics Inc stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
eToro
Stocks, Options, ETFs, Cryptocurrency
$0
$0
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
tastytrade
tastytrade
Stocks, Options, ETFs, Cryptocurrency, Futures
$0
$0
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
$0
$0
Get $50 - $700
when you open and fund an account with $10,000 - $250,000+
E*TRADE
Stocks, Bonds, Options, Mutual funds, ETFs, Futures
$0
$0
Get up to $600 or more
when you open and fund a new account.
E*TRADE offers commission-free stocks, access to mutual funds and advanced trading tools. Other fees apply.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy C4 Therapeutics Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

C4 Therapeutics Inc price performance over time

Historical closes compared with the close of $3.14 from 2023-03-31

1 week (2023-03-24) -11.30%
1 month (2023-03-01) -37.76%
3 months (2022-12-30) -46.78%
6 months (2022-09-30) -64.20%
1 year (2022-04-01) -87.47%
2 years (2021-04-01) -91.87%
3 years (2020-03-28) N/A
5 years (2018-03-28) N/A

C4 Therapeutics Inc financials

Revenue TTM $31.1 million
Gross profit TTM $-86,745,000
Return on assets TTM -17.27%
Return on equity TTM -37.76%
Profit margin 0%
Book value $5.91
Market capitalisation $152.1 million

TTM: trailing 12 months

C4 Therapeutics Inc share dividends

We're not expecting C4 Therapeutics Inc to pay a dividend over the next 12 months.

C4 Therapeutics Inc share price volatility

Over the last 12 months, C4 Therapeutics Inc's shares have ranged in value from as little as $2.995 up to $26.8. A popular way to gauge a stock's volatility is its "beta".

CCCC.US volatility(beta: 2.25)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while C4 Therapeutics Inc's is 2.2457. This would suggest that C4 Therapeutics Inc's shares are significantly more volatile than the average for this exchange and represent a higher risk.

To put C4 Therapeutics Inc's beta into context you can compare it against those of similar companies.

C4 Therapeutics Inc overview

C4 Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable BiDAC degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; CFT1946, an orally bioavailable BiDAC degrader targeting V600X mutant BRAF to treat melanoma, non-small cell lung cancer (NSCLC), colorectal cancer, and other solid malignancies; CFT8919, an orally bioavailable, allosteric, and mutant-selective BiDAC degrader of epidermal growth factor receptor, or EGFR, with an L858R mutation in NSCLC; and earlier stage programs comprising RET degraders for the treatment of various cancers. C4 Therapeutics, Inc. has strategic collaborations with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.

Frequently asked questions

What percentage of C4 Therapeutics Inc is owned by insiders or institutions?
Currently 11.375% of C4 Therapeutics Inc shares are held by insiders and 81.047% by institutions.
How many people work for C4 Therapeutics Inc?
Latest data suggests 146 work at C4 Therapeutics Inc.
When does the fiscal year end for C4 Therapeutics Inc?
C4 Therapeutics Inc's fiscal year ends in December.
Where is C4 Therapeutics Inc based?
C4 Therapeutics Inc's address is: 490 Arsenal Way, Watertown, MA, United States, 02472
What is C4 Therapeutics Inc's ISIN number?
C4 Therapeutics Inc's international securities identification number is: US12529R1077

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site